The Features section includes articles on topics, events, people, and initiatives of interest to the oncology community.
Oct 24, 2016
ASCO opened participant enrollment for the Targeted Agent and Profiling Utilization Registry (TAPUR) Study in March 2016, marking a major milestone in the conduct of the Society’s first-ever clinical trial.
Oct 21, 2016
There has been no better time than the present for women in the field of oncology, yet even with all of the hard-fought advances women in medicine have made over the last 40 years, challenges stemming from internalized biases at the personal and institutional level persist.
Oct 20, 2016
Dr. Maha Hussain is co-director of the Lurie Cancer Center Genitourinary Oncology Program, ASCO Board of Directors member, and ASCO Clinical Practice Guidelines Committee member.
Oct 13, 2016
Dr. Tom John reviews recent studies exploring immunotherapy as a treatment for mesothelioma, and considers the role of the Cancer Moonshot Initiative for facilitating new research in rare diseases.
Aug 24, 2016
Dr. Verweij is Dean of the Faculty of Medicine at Erasmus University, the Netherlands; Associate Editor for the Journal of Clinical Oncology; and ASCO Board of Directors Member
Dr. Michael J. Birrer Explores Molecular, Genetic, and Quality-of-Life Markers Among Long-Term Survivors of Ovarian Cancer
Aug 24, 2016
The innovative, holistic research strives to answer the question, are there biologic or quality-of-life markers that differentiate long-term survivors of ovarian cancer?
Aug 18, 2016
Lucy Kalanithi, MD, discusses her late husband's book, When Breath Becomes Air, an autobiographical account of Paul Kalanithi, MD, a physician diagnosed with lung cancer. The book was featured at the 2016 ASCO Annual Meeting.
Aug 18, 2016
ASCO’s data-driven rapid-learning system for cancer care is now being used by 65 vanguard practices around the United States, bringing more than 1,000 providers and 750,000 patient records into its fold.
Aug 15, 2016
Bruce E. Johnson, MD, FASCO, began his term as ASCO President- Elect in June 2016 and will serve as 2017-2018 President. Dr. Johnson is chief clinical research officer and institute physician at Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School.
Jun 29, 2016
Dr. Hurria is a geriatric oncologist at City of Hope, an ASCO member since 2001, a Board of Directors member, and Immediate Past Chair of the Professional Development Committee.